Blueprint® Mixed Reality Pilot Study
BLUEMR
A Pilot Single-Arm, Multicenter, Prospective, Post-Market 6 Months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINT™ (HOLOBLUEPRINT™).
BLUEMR
A Pilot Single-Arm, Multicenter, Prospective, Post-Market 6 Months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINT™ (HOLOBLUEPRINT™).
Sponsor study identifier
observational
44
1 country
4
Study Start
February 8, 2024
Actual (reported)Primary Completion
August 14, 2024
Actual (reported)Study Completion
May 7, 2025
Actual (reported)A pilot Single-Arm, Multicenter, Prospective, Post-Market 6 months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINT™ (HOLOBLUEPRINT™).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 7, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 6, 2022
Actual (reported)October 12, 2023
Actual (reported)February 8, 2024
Actual (reported)August 14, 2024
Actual (reported)May 7, 2025
Actual (reported)PERFORMANCE MEASUREMENT: Glenoid Implant Placement Accuracy
To describe the performance of HOLOBLUEPRINT™ by measuring the difference between postoperative implant placement compared with preoperative simulated implant placement. This will be performed using CT scans and a validated internally developed semi-automated software to compare the postoperative images with the preoperative planning.
15 days after surgery
DURATION OF THE INTERVENTION
Surgery
FUNCTIONAL EVALUATION AT 6 MONTHS (Range of motion)
6 months after surgery
One single cohort of patients receiving a reversed shoulder arthroplasty with the use of Blueprint Mixed Reality HOLOBLUEPRINT™ as per standard of care.
Patients with shoulder's condition requiring a shoulder surgery with a reversed implants. 50 patients are planned to be included in the study.
APHP Ambroise Paré
Boulogne-Billancourt, France
CHU de Brest
Brest, France
Centre Orthopédique Santy
Lyon, 69008, France
CHU de Tours
Tours, France
Rebecca Gibson
Stryker Trauma and Extremities
44 participants (actual enrollment reported by the registry).
First Submitted
July 6, 2022
First Posted
October 12, 2023
Study Start
February 8, 2024
Actual (reported)Isokinetic Fatigue Index in a Population of Triathletes
FUNCTIONAL EVALUATION AT 6 MONTHS (ASES Score)
6 months after surgery
PAIN EVALUATION AT 6 MONTHS (ASES Score)
6 months after surgery
FUNCTIONAL EVALUATION AT 6 MONTHS (Constant score)
6 months after surgery
Contact the study team to confirm eligibility.
Primary Completion
August 14, 2024
Actual (reported)Study Completion
May 7, 2025
Actual (reported)Last Updated
September 16, 2025
Record last verified: 2025-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: